Logo image of ZIVO

ZIVO BIOSCIENCE INC (ZIVO) Stock Fundamental Analysis

NASDAQ:ZIVO - Nasdaq - US98978N3098 - Common Stock - Currency: USD

1.1  -0.05 (-4.35%)

After market: 1.12 +0.02 (+1.82%)

Fundamental Rating

0

ZIVO gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 37 industry peers in the Personal Care Products industry. Both the profitability and financial health of ZIVO have multiple concerns. ZIVO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ZIVO had negative earnings in the past year.
In the past year ZIVO has reported a negative cash flow from operations.
In the past 5 years ZIVO always reported negative net income.
In the past 5 years ZIVO always reported negative operating cash flow.
ZIVO Yearly Net Income VS EBIT VS OCF VS FCFZIVO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -5M -10M

1.2 Ratios

ZIVO's Return On Assets of -404.76% is on the low side compared to the rest of the industry. ZIVO is outperformed by 94.87% of its industry peers.
Industry RankSector Rank
ROA -404.76%
ROE N/A
ROIC N/A
ROA(3y)-1550.36%
ROA(5y)-2266.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZIVO Yearly ROA, ROE, ROICZIVO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 20K 40K 60K 80K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ZIVO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZIVO Yearly Profit, Operating, Gross MarginsZIVO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 -10K -20K -30K -40K

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, ZIVO has about the same amount of shares outstanding.
Compared to 1 year ago, ZIVO has a worse debt to assets ratio.
ZIVO Yearly Shares OutstandingZIVO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 500K 1M 1.5M
ZIVO Yearly Total Debt VS Total AssetsZIVO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M

2.2 Solvency

ZIVO has an Altman-Z score of -94.02. This is a bad value and indicates that ZIVO is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -94.02, ZIVO is doing worse than 97.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -94.02
ROIC/WACCN/A
WACCN/A
ZIVO Yearly LT Debt VS Equity VS FCFZIVO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 10M -10M -20M

2.3 Liquidity

A Current Ratio of 0.62 indicates that ZIVO may have some problems paying its short term obligations.
ZIVO has a worse Current ratio (0.62) than 84.62% of its industry peers.
A Quick Ratio of 0.62 indicates that ZIVO may have some problems paying its short term obligations.
ZIVO has a Quick ratio of 0.62. This is in the lower half of the industry: ZIVO underperforms 71.79% of its industry peers.
Industry RankSector Rank
Current Ratio 0.62
Quick Ratio 0.62
ZIVO Yearly Current Assets VS Current LiabilitesZIVO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.67% over the past year.
EPS 1Y (TTM)1.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.97%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y85.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZIVO Yearly Revenue VS EstimatesZIVO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K
ZIVO Yearly EPS VS EstimatesZIVO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 -1 -2 -3 -4 -5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZIVO. In the last year negative earnings were reported.
Also next year ZIVO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZIVO Price Earnings VS Forward Price EarningsZIVO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZIVO Per share dataZIVO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ZIVO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZIVO BIOSCIENCE INC

NASDAQ:ZIVO (11/24/2023, 8:12:49 PM)

After market: 1.12 +0.02 (+1.82%)

1.1

-0.05 (-4.35%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-14 2023-11-14/amc
Earnings (Next)N/A N/A
Inst Owners0.01%
Inst Owner Change201.2%
Ins Owners128.97%
Ins Owner Change1.59%
Market Cap1.91M
Analysts82.86
Price Target36.72 (3238.18%)
Short Float %4.17%
Short Ratio1.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.84%
Min EPS beat(2)-7.84%
Max EPS beat(2)-7.84%
EPS beat(4)1
Avg EPS beat(4)-8.12%
Min EPS beat(4)-30.72%
Max EPS beat(4)14.22%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-95.1%
Min Revenue beat(2)-95.1%
Max Revenue beat(2)-95.1%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)500%
PT rev (3m)500%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 191.4
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.58
EYN/A
EPS(NY)-0.82
Fwd EYN/A
FCF(TTM)-3.75
FCFYN/A
OCF(TTM)-3.75
OCFYN/A
SpS0.01
BVpS-0.63
TBVpS-0.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -404.76%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1550.36%
ROA(5y)-2266.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.62
Quick Ratio 0.62
Altman-Z -94.02
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.97%
EPS Next Y85.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-0.54%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.41%
OCF growth 3YN/A
OCF growth 5YN/A